102 related articles for article (PubMed ID: 27252517)
41. Nucleic acid vaccine-induced immune responses require CD28 costimulation and are regulated by CTLA4.
Horspool JH; Perrin PJ; Woodcock JB; Cox JH; King CL; June CH; Harlan DM; St Louis DC; Lee KP
J Immunol; 1998 Mar; 160(6):2706-14. PubMed ID: 9510170
[TBL] [Abstract][Full Text] [Related]
42. [Costimulatory molecules in autoimmunity: role of CD28/CTLA4-CD80/CD86].
Nakajima A; Azuma M
Nihon Rinsho; 1997 Jun; 55(6):1419-24. PubMed ID: 9200926
[TBL] [Abstract][Full Text] [Related]
43. Cytotoxic T lymphocyte antigen 4 (CTLA-4) inhibits CD28-induced IkappaBalpha degradation and RelA activation.
Pioli C; Gatta L; Frasca D; Doria G
Eur J Immunol; 1999 Mar; 29(3):856-63. PubMed ID: 10092088
[TBL] [Abstract][Full Text] [Related]
44. T cells of staphylococcal enterotoxin B-tolerized autoimmune MRL-lpr/lpr mice require co-stimulation through the B7-CD28/CTLA-4 pathway for activation and can be reanergized in vivo by stimulation of the T cell receptor in the absence of this co-stimulatory signal.
Zhou T; Weaver C; Linsley PS; Mountz JD
Eur J Immunol; 1994 May; 24(5):1019-25. PubMed ID: 7514125
[TBL] [Abstract][Full Text] [Related]
45. The role of the CD28 receptor during T cell responses to antigen.
Linsley PS; Ledbetter JA
Annu Rev Immunol; 1993; 11():191-212. PubMed ID: 8386518
[TBL] [Abstract][Full Text] [Related]
46. Increased total serum IgE levels in patients with asthma and promoter polymorphisms at CTLA4 and FCER1B.
Hizawa N; Yamaguchi E; Jinushi E; Konno S; Kawakami Y; Nishimura M
J Allergy Clin Immunol; 2001 Jul; 108(1):74-9. PubMed ID: 11447385
[TBL] [Abstract][Full Text] [Related]
47. Medullary thymic epithelium expresses a ligand for CTLA4 in situ and in vitro.
Nelson AJ; Hosier S; Brady W; Linsley PS; Farr AG
J Immunol; 1993 Sep; 151(5):2453-61. PubMed ID: 8395547
[TBL] [Abstract][Full Text] [Related]
48. Synergistic induction of CTLA-4 expression by costimulation with TCR plus CD28 signals mediated by increased transcription and messenger ribonucleic acid stability.
Finn PW; He H; Wang Y; Wang Z; Guan G; Listman J; Perkins DL
J Immunol; 1997 May; 158(9):4074-81. PubMed ID: 9126965
[TBL] [Abstract][Full Text] [Related]
49. Association studies of CTLA-4, CD28, and ICOS gene polymorphisms with type 1 diabetes in the Japanese population.
Ihara K; Ahmed S; Nakao F; Kinukawa N; Kuromaru R; Matsuura N; Iwata I; Nagafuchi S; Kohno H; Miyako K; Hara T
Immunogenetics; 2001 Aug; 53(6):447-54. PubMed ID: 11685455
[TBL] [Abstract][Full Text] [Related]
50. CD28/CTLA-4 and CD80/CD86 families: signaling and function.
Slavik JM; Hutchcroft JE; Bierer BE
Immunol Res; 1999; 19(1):1-24. PubMed ID: 10374692
[TBL] [Abstract][Full Text] [Related]
51. [CD28/B7 costimulating signal and its clinical significance].
Qu MH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Jun; 10(3):265-7. PubMed ID: 12513801
[TBL] [Abstract][Full Text] [Related]
52. B7.2 expressed by T cells does not induce CD28-mediated costimulatory activity but retains CTLA4 binding: implications for induction of antitumor immunity to T cell tumors.
Greenfield EA; Howard E; Paradis T; Nguyen K; Benazzo F; McLean P; Höllsberg P; Davis G; Hafler DA; Sharpe AH; Freeman GJ; Kuchroo VK
J Immunol; 1997 Mar; 158(5):2025-34. PubMed ID: 9036945
[TBL] [Abstract][Full Text] [Related]
53. Role of CD80, CD86, and CTLA4 on mouse CD4(+) T lymphocytes in enhancing cell-cycle progression and survival after activation with PMA and ionomycin.
Mukherjee S; Maiti PK; Nandi D
J Leukoc Biol; 2002 Nov; 72(5):921-31. PubMed ID: 12429713
[TBL] [Abstract][Full Text] [Related]
54. CTLA-4 and CD28: similar proteins, neighbouring genes.
Balzano C; Buonavista N; Rouvier E; Golstein P
Int J Cancer Suppl; 1992; 7():28-32. PubMed ID: 1330947
[TBL] [Abstract][Full Text] [Related]
55. Genetic analysis of the 2q33 region containing CD28-CTLA4-ICOS genes: association with non-Hodgkin's lymphoma.
Piras G; Monne M; Uras A; Palmas A; Murineddu M; Arru L; Bianchi A; Calvisi A; Curreli L; Gaviano E; Lai P; Murgia A; Latte GC; Noli A; Gabbas A
Br J Haematol; 2005 Jun; 129(6):784-90. PubMed ID: 15953005
[TBL] [Abstract][Full Text] [Related]
56. Blocking CD40 - CD154 and CD80/CD86 - CD28 interactions during primary allogeneic stimulation results in T cell anergy and high IL-10 production.
Van Gool SW; Vermeiren J; Rafiq K; Lorr K; de Boer M; Ceuppens JL
Eur J Immunol; 1999 Aug; 29(8):2367-75. PubMed ID: 10458748
[TBL] [Abstract][Full Text] [Related]
57. B7-CD28/CTLA-4 costimulatory pathways are required for the development of T helper cell 2-mediated allergic airway responses to inhaled antigens.
Keane-Myers A; Gause WC; Linsley PS; Chen SJ; Wills-Karp M
J Immunol; 1997 Mar; 158(5):2042-9. PubMed ID: 9036947
[TBL] [Abstract][Full Text] [Related]
58. Molecular alterations in the TCR signaling pathway in patients with aplastic anemia.
Li B; Guo L; Zhang Y; Xiao Y; Wu M; Zhou L; Chen S; Yang L; Lu X; Li Y
J Hematol Oncol; 2016 Mar; 9():32. PubMed ID: 27036622
[TBL] [Abstract][Full Text] [Related]
59. Clinical significance of CD28 gene-related activating alterations in adult T-cell leukaemia/lymphoma.
Sakamoto Y; Ishida T; Masaki A; Takeshita M; Iwasaki H; Yonekura K; Tashiro Y; Ito A; Kusumoto S; Utsunomiya A; Iida S; Ueda R; Inagaki H
Br J Haematol; 2021 Jan; 192(2):281-291. PubMed ID: 33205842
[TBL] [Abstract][Full Text] [Related]
60. CD28 fusions: an opportunity for young ATL?
Cook LBM; Rowan AG
Blood; 2020 Apr; 135(17):1415-1416. PubMed ID: 32324866
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
